Nitidine chloride (NC), a quaternary ammonium alkaloid, has numerous pharmacological effects, such as anticancer activity. However, it was found that NC also has hepatocellular toxicity. Because organic cation transporters 1 and 3 (OCT1 and OCT3) might mediate the influx of NC into hepatocytes, multidrug and toxin extrusion 1 (MATE1) probably mediates the efflux of NC from hepatocytes, while cytochrome P450 (P450) enzymes might contribute to NC metabolism, the present study was to evaluate the contribution of OCT1, OCT3, MATE1, and P450 enzymes to NCinduced hepatocellular toxicity. Our results showed that the uptake of NC in Madin-Darby canine kidney (MDCK) cells expressing human (h) OCT1 and OCT3 (MDCK-hOCT1 and MDCK-hOCT3) was significantly higher than that in mock cells; the hOCT1-and hOCT3-mediated uptake followed typical Michaelis-Menten kinetics.
Introduction
Nitidine chloride (NC) (Fig. 1) , a natural bioactive phytochemical alkaloid isolated from the root of Zanthoxylum nitidum (Roxb.) DC (Arthur et al., 1959) , was reported to have significant antimalarial (Gakunju et al., 1995) , anti-human immunodeficiency virus (Tan et al., 1991) , antimicrobial, and analgesic activities (Del Poeta et al., 1999; Hu et al., 2006) . Recently, a number of studies found that NC showed anticancer potential in several tumor types, including osteosarcoma, gastric cancer, and liver cancer (Lv et al., 2011; Chen et al., 2012; Liao et al., 2013) . The anticancer activity of NC was correlated with its ability to decrease cell growth, induce cell apoptosis, and arrest cell cycles in a variety of human cancer cell lines, such as MG-63 and KB osteosarcoma cell lines (Liu et al., 2007; Xu et al., 2011) . Meanwhile, the tumor-selective cytotoxicity of NC was found to be attributed to intercalation into DNA and inhibition of topoisomerase I and II (Gatto et al., 1996; Holden et al., 1999; Iwasaki et al., 2010; Pan et al., 2011) . Additionally, NC could inhibit hepatocellular carcinoma cell growth in vivo (Liu et al., 2009; Liao et al., 2013) . Thus, NC is thought to be a promising anticancer drug candidate.
Drug safety is one of the determining factors in the successful clinical development of a new drug (Khanna, 2012) . Although the toxicity of anticancer drugs is much more tolerable than that of other drugs, the severe toxicity to the heart (Curigliano et al., 2012) , liver (Wolff et al., 1998) , and kidney (Mahmoud and El Shazly, 2013) induced by anticancer drugs is still unacceptable.
The liver, a major contributor to the disposition of drugs, has a wide range of xenobiotic-metabolizing enzymes as well as transporters, and it is a target organ of drug-induced toxicity and subsequently various disorders. There are some reports of hepatocellular toxicity caused by NC (Liu and Liu, 2010; Huang et al., 2011) . Because NC is a quaternary ammonium alkaloid, it will mainly be a cation at physiologic pH, and the passive permeation is likely to be low; therefore NC was speculated to be transported by some transporters on the cellular membrane.
The polyspecific organic cation transporters (OCTs) of the SLC22 family, including OCT1, OCT2, and OCT3, have been reported to play important roles in the transport of organic cations, such as weak 
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, 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide; CL int , intrinsic clearance; DMSO, dimethylsulfoxide; FBS, fetal bovine serum; h, human; HBSS, Hanks' balanced salt solution; HLM, human liver microsome; LC-MS/MS, liquid chromatography-tandem mass spectrometry; LDH, lactate dehydrogenase; MATE1, multidrug and toxin extrusion 1; MDCK, Madin-Darby canine kidney; MDR1, multidrug resistance protein 1; MPP bases (Koepsell et al., 2007; Nies et al., 2011) . OCT1 is located mainly in the sinusoidal membrane of hepatocytes (Koepsell et al., 2003; Nies et al., 2009) and mediates the first step in hepatocellular uptake of many cationic drugs and xenobiotics. OCT3 is more broadly expressed in the body (Koepsell et al., 2007; Nies et al., 2011) , such as in the liver and brain (Nies et al., 2009) , and is involved in the disposition of various exogenous and endogenous compounds. Additionally, human (h) multidrug and toxin extrusion 1 (MATE1) is abundantly expressed in the canalicular membrane of hepatocytes (Omote et al., 2006) and acts as an H + /organic cation exporter. Based on the structure of NC and the localization of OCTs and MATE1, we proposed that OCT1 and/or OCT3 potentially mediate the influx of NC into hepatocytes, while MATE1 probably mediates the efflux of NC from hepatocytes; thus, OCT1, OCT3, and/or MATE1 might play a crucial role in NC-induced hepatocellular toxicity.
On the other hand, metabolism is the main route of clearance for approximately 70% of currently used drugs, and the liver is a major site of metabolism for a wide range of xenobiotics. Cytochrome P450 (P450) enzymes in liver, including CYP3A4, CYP2C9, CYP2C19, CYP2D6, etc., are the most important phase I enzymes (Krishna and Klotz, 1994) , which catalyze primarily oxidative metabolism of drugs and other xenobiotics (Brown et al., 2008) . The metabolism mediated by P450 enzymes may inactivate or activate the xenobiotics; however, the contribution of P450-mediated metabolism to NC-induced hepatocellular toxicity has not been elucidated.
With this in mind, the aim of the present study was to investigate the effects of OCT1, OCT3, and MATE1 on the transport of NC in hepatocytes and subsequently to assess the role of OCT1 and OCT3 in hepatotoxicity induced by NC using Madin-Darby canine kidney (MDCK) cells stably expressing human OCT1 and OCT3 (MDCKhOCT1 and MDCK-hOCT3) and primary cultured rat hepatocytes. The contribution of P450-mediated metabolism in NC-induced hepatocellular toxicity using double-transfected MDCK cells expressing hOCT1 and hCYP3A4 (MDCK-hOCT1/hCYP3A4) was also investigated. These results give us more information about the possible mechanisms and risk factors associated with hepatocellular toxicity of NC and provide the basis for the development of strategies targeted to attenuate its hepatocellular toxicity.
Materials and Methods
Fetal bovine serum (FBS), G418, trypsin, Dulbecco's modified Eagle's medium, and RPMI 1640 medium were purchased from Gibco (Invitrogen Life Technologies, Grand Island, NY). 1-Methyl-4-phenylpyridinium iodide (MPP + ), loratadine, 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP + ), quercetin, sertraline, furafylline, pilocarpine, cimetidine, sulfaphenazole, nootkatone, ketoconazole, quinidine, diethyldithiocarbamate, testosterone, nifedipine, b-NADP, b-NADPH, isocitric dehydrogenase, and isocitric acid were obtained from Sigma-Aldrich (St. Louis, MO). NC and (+)-tetrahydropalmatine [(+)-THP] were purchased respectively from Nanjing Zelang Medical Technology Co., Ltd. (Nanjing, China) and Huatuo Co., Ltd. (Shanghai, China). 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) was obtained from Sangon Biotech Co., Ltd. (Shanghai, China). P450-Glo CYP3A4 Assay (Luciferin-IPA) was purchased from Promega (Madison, WI). Lactate dehydrogenase (LDH) activity assay kit and bicinchoninic acid protein assay kit were obtained from Jiancheng Co., Ltd. (Nanjing, China) and Beyotime Institute of Biotechnology (Beyotime, China), respectively. Acetonitrile was obtained from Tedia (Fairfield, OH). All other chemicals were purchased from commercial sources and were of analytical grade.
Microsomes and P450 Enzymes. Pooled human liver microsomes (HLMs; lot FZTO) and recombinant human CYP3A4 (rhCYP3A4), rhCYP2D6, rhCYP2C8, and rhCYP2B6 were obtained from Research Institute for Liver Diseases (Shanghai) Co., Ltd. (Shanghai, China). Information related to protein concentration, P450 isoform content, and enzyme activity of the products was supplied by the manufacturer. The HLMs and rhCYP3A4, rhCYP2D6, rhCYP2C8, and rhCYP2B6 were stored at 280°C until use.
Animals. Male Sprague-Dawley rats, ;180-200 g, were obtained from the Experimental Animal Center of the Zhejiang Academy of Medical Sciences. The rats were maintained in cages at controlled temperature (20-23°C) and humidity (50%-60%) in a 12-hour light/dark cycle with free access to food and water. Animals were fasted for 12 hours before experiments. The experimental procedures were approved by the Institutional Animal Care and Use Committee of Zhejiang University Medical Center.
Cell Culture. The MDCK cell line was obtained from Peking Union Medical College (Beijing, China). MDCK cells stably transfected with plasmid pcDNA3.1(+) vector containing human OCT1 cDNA (MDCK-hOCT1), human OCT3 cDNA (MDCK-hOCT3), human MATE1 cDNA (MDCK-hMATE1), and empty vector (mock cells) were constructed in our laboratory (Tu et al., 2013; Sun et al., 2014) . The activity of hOCT1 and hOCT3 in the stably transfected cells was validated by model substrates, such as ASP + and MPP + , with or without quinidine, an OCT1 and OCT3 inhibitor (Hasannejad et al., 2004; Ahlin et al., 2008) . The activity of hMATE1 was validated by the model substrate MPP + with or without cimetidine, a MATE1 inhibitor (Nies et al., 2011) . The double-transfected MDCK-hOCT1/hCYP3A4 cell model was obtained by transfecting the single-transfected MDCK-hOCT1 cells with the plasmid pcDNA3.1/Hygro(+) vector containing human CYP3A4 cDNA. The activity of hCYP3A4 in the double-transfected cells was validated by P450-Glo CYP3A4 Assay (Luciferin-IPA), with or without the CYP3A4 inhibitor ketoconazole (Hashizume et al., 2010) . The mRNA expression, protein expression, and uptake function of OCT1 of MDCK-hOCT1 and MDCKhOCT1/CYP3A4 cells were confirmed to be at approximate level by real-time reverse-transcription polymerase chain reaction, Western blot analysis, and uptake study, respectively. Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated FBS, 100 units/ml penicillin, 100 mg/ml streptomycin, and 700 mg/ml G418 or 400 mg/ml hygromycin B (for double-transfected cells) at 37°C with 5% CO 2 and 95% humidity. The cells were subcultured after being 90% confluent with 0.25% trypsin.
Primary Rat Hepatocyte Isolation and Culture. Primary rat hepatocytes were isolated from liver of male rats by a modified two-step collagenase perfusion method (Lu et al., 2011) . The cells (viability, .85%) were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 100 units/ml penicillin, and 100 mg/ml streptomycin and then seeded in poly-D-lysine-coated 12-well plates or 96-well plates (Corning Costar Inc., Corning, NY) at a density of 3 Â 10 5 /well or 1 Â 10 4 /well. The cells were cultured at 37°C in a 5% CO 2 and 95% air humidified incubator for 4 hours to be attached to the plates.
Cellular Uptake Assays. MDCK-hOCT1, MDCK-hOCT3, and mock cells were seeded in 24-well plates at a density of 2 Â 10 5 /well. Cells were cultured for 3 days and washed twice with Hanks' balanced salt solution (HBSS); then the uptake studies were performed as in our previous method (Tu et al., 2013) . Briefly, the cells were preincubated with HBSS (37°C, 10 minutes), and then 200 ml of HBSS containing MPP + or NC in the absence or presence of different inhibitors was added to initiate the uptake. The incubation was performed at 37°C; then the reaction was terminated by removing the incubation buffer and adding ice-cold buffer quickly at the designated time. Then the cells were washed three times with ice-cold buffer and lysed with 100 ml of 0.1% SDS. The hOCT1-or hOCT3-mediated uptake was obtained by subtracting To determine whether NC is a substrate of hMATE1, the cellular uptake study was performed as the method for MDCK-hOCT1 cells, except that the cells were treated with ammonium chloride (20 mM; pH 7.4) at 37°C for 20 minutes to generate the intracellular acidification prior to the uptake study (Lang et al., 2003; Masuda et al., 2006) , and AUB buffer (130 mM KCl, 1 mM CaCl 2 , 1.1 mM Mg 2 SO 4 ·7H 2 O, 2.6 mM K 2 HPO 4 , 5.5 mM glucose, and 25 mM HEPES; pH 7.4) replaced HBSS solution. The cells were preincubated with AUB buffer at 37°C for 5 minutes, and the uptake was initiated by adding AUB buffer containing NC or MPP + in the absence or presence of different inhibitors, following the procedures described above.
The uptake conditions, such as the concentrations and the time course, of MPP + and NC were optimized in our preliminary experiments, and the appropriate time points or the concentrations in the initial linear phase (i.e., initial uptake rates) were selected for determination of kinetic parameters (Brouwer et al., 2013) . All experiments were performed in triplicate. The uptake of MPP + and NC in the cells was quantified with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and normalized to the total protein content in the lysates with a bicinchoninic acid protein assay kit. The uptake in the presence of inhibitors was expressed as the percentage of the vehicle group (% of control).
Cytotoxicity Assay. The cytotoxicity of NC was assessed in MDCKhOCT1, MDCK-hOCT3, MDCK-hOCT1/hCYP3A4, and mock cells and primary cultured rat hepatocytes seeded in 96-well plates. Cells were incubated with medium containing NC or 0.2% dimethylsulfoxide (DMSO) as vehicle with or without OCT1 and OCT3 inhibitors at 37°C for 24 hours. At the end of the incubation, the medium was collected for measuring LDH activity using the LDH activity assay kit. Then 20 ml of MTT reagent was added to each well and the mixture was incubated for another 4 hours. Subsequently the incubation medium was removed and 150 ml of DMSO was added to dissolve the formazan. The absorbance of each well was measured at 570 nm with 630 nm as a reference by a microplate reader (Spectra Max M2; Molecular Devices, Sunnyvale, CA), and cell viability was expressed as a percentage of the vehicle group (0.2% DMSO).
Prediction of Relative Contribution of P450 Isoforms in NC Metabolism. To study the contribution of P450 isoforms in the metabolism of NC, a substrate depletion approach was adopted (Zomorodi et al., 1995) . The enzyme concentrations as well as the incubation times were chosen according to the preliminary results demonstrating that the NC depletion was linear under these conditions (Jones and Houston, 2004) , and the incubations were performed as in our previous study with some modifications . NC (0.2 mM) was preincubated with 0.5 mg protein/ml of HLMs, 25 pmol P450/ml of rhCYP3A4, 15 pmol P450/ml of rhCYP2D6, and 25 pmol P450/ml of rhCYP2C8 or rhCYP2B6 at 37°C for 3 minutes in 100 ml incubation system (14.9 mM isocitric acid, 0.035 units/ml isocitric dehydrogenase, 0.15 M MgCl 2 , and 0.1 M Tris-HCl buffer; pH 7.4). The inhibitors (10 mM) of various P450 isoforms-furafylline (CYP1A2), pilocarpine (CYP2A6), sertraline (CYP2B6), quercetin (CYP2C8), sulfaphenazole (CYP2C9), nootkatone (CYP2C19), quinidine (CYP2D6), diethyldithiocarbamate (CYP2E1), and ketoconazole (CYP3A4)-were applied respectively to determine which P450 isoforms were responsible for NC metabolism. The reaction was initiated by adding NADP/NADPH (27 mM/12 mM) and continued at 37°C for a designated time (30 minutes for HLMs, 60 minutes for rhCYP3A4, 5 minutes for rhCYP2D6, and 30 minutes for rhCYP2C8 and rhCYP2B6). All incubations were performed in triplicate. The concentration of NC in HLMs and recombinant human P450 enzymes was quantified with LC-MS/MS, and the metabolism in the presence of inhibitors was expressed as the percentage of the vehicle group (% of control).
LC-MS/MS Determination of MPP + and NC. The concentrations of MPP + and NC in the uptake and metabolism samples were determined by modified LC-MS/MS methods (Zhang et al., 2008) using an Agilent 1290/6460 LC-MS (Agilent Technologies, Santa Clara, CA) with a triple quadrupole mass spectrometer. Two volumes of acetonitrile containing 90 ng/ml loratadine as internal standard were added into the cell lysates or incubation medium to precipitate the proteins. After vortex-mixing for 2 minutes, the mixture was centrifuged at 16,000g for 15 minutes and the supernatant was analyzed by LC-MS/MS. The high-performance liquid chromatography separation was performed on an Agilent XDB C 18 column (2.1 Â 50 mm, 3.5 mm) with a gradient mobile phase consisting of 0.1% formic acid-water and 0.1% formic acidacetonitrile at a flow rate of 0.3 ml/min. The mass spectrometric analysis was performed using an electrospray ionization source in positive ion mode, and the quantification was obtained using multiple reaction monitoring mode (the ion pair of MPP + at m/z 170.1 → 128.0, NC at m/z 348.1 → 332.1, or internal standard at m/z 383.1 → 337.1). The conditions for mass spectrometric analysis were as follows: capillary voltage of 3500 V, gas temperature of 350°C, gas flow of 5 l/min, nebulizing pressure of 45 psi, sheath gas temperature of 350°C, sheath gas flow of 11 l/min, and nozzle voltage of 500 V.
Data Analysis. Data are expressed as mean 6 S.D. The IC 50 values were assessed by nonlinear regression fitting using GraphPad Prism 5.0 (GraphPad Software Inc., La Jolla, CA). The Michaelis-Menten constants V max and K m were calculated by fitting the data to the Michaelis-Menten equation
, where V is the uptake velocity and [S] is the concentration of substrate. Statistical differences were determined using one-way analysis of variance with Bonferroni test for selected pairs of groups; P values , 0.05 were considered statistically significant.
Results
Inhibitory Effect of NC on MPP + Uptake Mediated by hOCT1 or hOCT3. To determine whether NC interacts with hOCT1 or hOCT3, the inhibitory effect of NC (0.001-100 mM) on the uptake of MPP + (1 mM; 3 minutes) in MDCK-hOCT1 or MDCK-hOCT3 cells was evaluated. As shown in Fig. 2A , NC inhibited the uptake of MPP + in a concentration-dependent manner, with IC 50 values of 1.09 6 0.077 mM and 0.638 6 0.12 mM, respectively, while the IC 50 values of two known inhibitors of OCT1/OCT3, quinidine and (+)-THP (Tu et al., 2013) , were 2.47 6 0.74 mM and 12.4 6 1.7 mM for hOCT1 and 1.52 6 0.28 mM and 9.42 6 0.37 mM for hOCT3, respectively (Fig. 2, B and C) .
Uptake of NC Mediated by hOCT1, hOCT3, or hMATE1. The function of the MDCK-hOCT1 and MDCK-hOCT3 cells was confirmed by comparing the uptake of model substrate MPP + (1 mM; 3 minutes) in MDCK-hOCT1 or MDCK-hOCT3 with that of mock cells. The uptake of MPP + in MDCK-hOCT1 and MDCKhOCT3 cells was 62-and 30-fold higher than that in mock cells. To determine whether NC is a substrate of hOCT1 and/or hOCT3, the intracellular uptake of NC in MDCK-hOCT1 or MDCK-hOCT3 cells and mock cells was compared at physiologic pH. Based on the uptaketime and uptake-concentration curves shown in Fig. 3 , the uptake of NC in MDCK-hOCT1 or MDCK-hOCT3 cells was much higher than that in mock cells. The kinetic study results showed that the uptake of NC in mock cells was linear in the concentration range of 0.1-4 mM, while the hOCT1-or hOCT3-mediated uptake followed MichaelisMenten kinetics, with K m and V max values of 0.797 6 0.17 mM and 249 6 24 pmol/mg protein per minute and 2.49 6 0.45 mM and 25.4 6 1.1 pmol/mg protein per minute, respectively (Fig. 3, B and D) . The above results indicated that NC is a substrate of hOCT1 and hOCT3, and the uptake by hOCT1 was much greater than that by hOCT3, indicating that NC is a selective substrate of hOCT1.
The function of MDCK-hMATE1 cells was confirmed by comparing the uptake of model substrate MPP + (1 mM; 3 minutes) in MDCK-hMATE1 and mock cells, and the uptake of MPP + in MDCK-hMATE1 was 48-fold of that in mock cells. Since the substrates of MATE1 overlap with those of OCT1, to determine whether NC is a substrate of transporters expressed in the bile canalicular membrane, such as MATE1, the intracellular uptake of NC in MDCK-hMATE1 cells was compared with that in mock cells. In both time-and concentration-dependent manners, the uptake of NC in MDCK-hMATE1 cells was much higher than that in mock cells (Fig. 3) . The kinetic study showed that the uptake of NC in mock cells was linear in the concentration range of 0.1-4 mM), while the hMATE1-mediated uptake followed Michaelis-Menten kinetics, with K m and V max values dmd.aspetjournals.org of 0.897 6 0.085 mM and 18.5 6 1.0 pmol/mg protein per minute, respectively (Fig. 3F) . The above results indicated that NC is also a substrate of hMATE1, whereas its transport capacity was much lower than that of OCT1.
Inhibitory Effects of OCT1 and OCT3 Inhibitors on NC Uptake by hOCT1 or hOCT3. To further confirm the effect of OCT1 or OCT3 on the uptake of NC, uptake studies of NC (0.2 mM; 2 minutes) in MDCK-hOCT1 or MDCK-hOCT3 and mock cells were performed with or without inhibitors of OCT1 and OCT3. The results revealed that quinidine (50 mM) or (+)-THP (50 mM), OCT1 and OCT3 inhibitors, reduced NC uptake in MDCK-hOCT1 or MDCK-hOCT3 cells to the level in mock cells, while the uptake in mock cells was not influenced (Fig. 4A) , indicating the involvement of OCT1 or OCT3 in the hepatic cellular uptake of NC.
Because both OCT1 and OCT3 are located in hepatocytes, and many hepatic cell lines have low or no expression of transporters and metabolic enzymes, primary cultured rat hepatocytes were applied to study the OCT1-or OCT3-mediated hepatocellular uptake of NC. The rat hepatocytes were incubated with 1 mM NC at 37°C for 2 minutes with or without 50 mM OCT1 and OCT3 inhibitors [quinidine and (+)-THP], and the uptake of NC by hepatocytes was significantly reduced by (+)-THP or quinidine (P , 0.001) (Fig. 4B) . The results further demonstrated that OCT1 and/or OCT3 played an important role in the uptake of NC in primary cultured rat hepatocytes.
The Contribution of OCT1 and OCT3 to NC-Induced Cytotoxicity. The above results demonstrated that NC is a substrate of OCT1 and OCT3; therefore we investigated whether OCT1 and/or OCT3 play important roles in NC-induced hepatotoxicity. MDCKhOCT1, MDCK-hOCT3, or mock cells were incubated with NC (0.01-100 mM) at 37°C for 24 hours, and the cell viability was measured. The results revealed that both MDCK-hOCT1 and MDCKhOCT3 cells were much more sensitive to NC cytotoxicity than mock cells, and the IC 50 values in MDCK-hOCT1 and MDCK-hOCT3 cells were 0.163 6 0.027 mM and 0.522 6 0.072 mM, respectively, while the IC 50 in mock cells was 17.0 6 4.2 mM (Fig. 5A) .
To confirm the contribution of OCT1 and OCT3 to the cytotoxicity of NC, the effects of the OCT1 and OCT3 inhibitors quinidine and (+)-THP on NC-induced cytotoxicity in MDCK-hOCT1 and MDCKhOCT3 cells were studied by measuring cell viability and LDH activity in cell culture medium. The results showed that (+)-THP (10, 50 mM) or quinidine (10, 50 mM) markedly attenuated the cell viability reduction (P , 0.05) and reduced the LDH activity increase caused by 0.5 mM NC (P , 0.01) (Fig. 5, B and C) .
NC-Induced Hepatotoxicity in Primary Cultured Rat Hepatocytes. Since we demonstrated that OCT1 and OCT3 played important roles in the uptake of NC in hepatocytes, primary cultured rat hepatocytes were applied to confirm the hepatotoxicity induced by NC. Figure 6A shows that NC reduced the cellular viability in a concentration-dependent manner (0.01-100 mM), with an IC 50 of 2.83 6 0.53 mM. As the cells were treated with 1 mM NC for 24 hours, the cellular viability was decreased to 80.7% 6 3.8% of the vehicle group, and (+)-THP (10, 50 mM) markedly attenuated the viability reduction (P , 0.01), whereas quinidine (10, 50 mM) did not affect the viability of hepatocytes (Fig. 6B) .
NC Was Metabolized by Human P450 Enzymes. Because liver P450 enzymes mediate the metabolism of a great number of compounds, we reasoned that P450 enzymes might mediate the metabolism of NC and subsequently affect the cytotoxicity of NC. To confirm our deduction and further elucidate which P450 isoforms are responsible for NC metabolism, we studied the metabolism of NC in HLMs with or without inhibitors of P450 enzymes. The results demonstrated that NC (0.2 mM; 30 minutes) was metabolized by HLMs and that ketoconazole (10 mM), quercetin (10 mM), quinidine (10 mM), and sertraline (10 mM), inhibitors of CYP3A4, CYP2C8, CYP2D6, and CYP2B6, markedly inhibited the metabolism of NC (P , 0.001), which decreased the metabolism of NC to 67.5% 6 2.6%, 45.6% 6 4.9%, 82.0% 6 1.6%, and 76.3% 6 0.33%, respectively, of that of vehicle (0.1% DMSO) (Fig. 7A) . The above results indicated that CYP3A4, CYP2C8, CYP2D6, and CYP2B6 might be involved in the metabolism of NC.
The subsequent study showed that NC was dramatically metabolized by rhCYP3A4, rhCYP2D6, rhCYP2C8, and rhCYP2B6, and that the metabolism followed Michaelis-Menten kinetics. K m and V max were 0.773 mM and 4.08 pmol/h per picomole P450 for rhCYP3A4, 0.338 mM and 365.2 pmol/h per picomole P450 for rhCYP2D6, 1.17 mM and 4.23 pmol/h per picomole P450 for rhCYP2C8, and 1.63 mM and 26.46 pmol/h per picomole P450 for rhCYP2B6, respectively (Fig. 7,  B-E) . The above data demonstrated that NC is a substrate of CYP3A4, CYP2D6, CYP2C8, and CYP2B6 with high affinity.
CYP3A4 Attenuates the Cytotoxicity Induced by NC. In the present study, we chose CYP3A4 to further study the role of P450 enzymes in NC-induced hepatocellular toxicity. Since we found that the typical CYP3A4 inhibitors, such as ketoconazole, verapamil, and indinavir, also inhibited hOCT1, we could not use them to determine CYP3A4's role in toxicity. Therefore double-transfected MDCKhOCT1/hCYP3A4 cells were applied to further confirm the effect of CYP3A4 on hepatotoxicity induced by NC. The activity of hOCT1 upon CYP3A4 cotransfection was confirmed by the uptake of model substrate ASP + (1 mM; 15 minutes), and the uptake of ASP + in MDCK-hOCT1/hCYP3A4 cells was nearly identical to that in MDCK-hOCT1 cells (data not shown). As shown in Fig. 8 , the viability of MDCK-hOCT1 and MDCK-hOCT1/hCYP3A4 cells was reduced in the presence of NC (0.25-100 mM) in a concentrationdependent manner; however, the viability of MDCK-hOCT1/hCYP3A4 cells was significantly higher than that of MDCK-hOCT1 cells under the same conditions of NC (0.25-10 mM) treatment (P , 0.05). The above results suggested that CYP3A4-mediated metabolism may attenuate the hepatocellular toxicity of NC.
Discussion
In the present study, we evaluated the contribution of OCT1, OCT3, and CYP3A4 in the disposition and hepatocellular toxicity of NC using an hOCT1-or hOCT3-transfected MDCK cell model, doubletransfected hOCT1/hCYP3A4 cell model, and primary cultured rat hepatocytes. We demonstrated the following. 1) The cellular accumulation of NC in MDCK-hOCT1 or MDCK-hOCT3 cells was significantly higher than that in mock cells, and OCT1 and OCT3 inhibitors markedly reduced the uptake of NC in MDCK-hOCT1 or MDCK-hOCT3 cells but not in mock cells. 2) NC was also a substrate of hMATE1, but the transport capacity was much lower than that of hOCT1 based on comparison of their kinetic parameters [intrinsic clearance (CL int )].
3) The cytotoxicity induced by NC in MDCKhOCT1 or MDCK-hOCT3 cells was obviously higher than that in mock cells or primary cultured rat hepatocytes, and (+)-THP, an inhibitor of OCT1 and OCT3, significantly attenuated the NC-induced toxicity. 4) CYP3A4 was one of the main P450 isoforms that mediated the metabolism of NC, and the NC-induced toxicity in MDCK-hOCT1 cells was greater than that in MDCK-hOCT1/hCYP3A4 cells. The above results indicated that NC is a substrate of hOCT1, hOCT3, and CYP3A4; OCT1 and OCT3 located in hepatocyte membranes mediate the uptake of NC and subsequently cause the toxicity; and CYP3A4 in hepatocytes mediates the metabolism of NC and attenuates the NCinduced toxicity.
Our results demonstrated for the first time that NC is a substrate of OCT1 and OCT3, which could explain the difference between the NCinduced toxicity in hOCT1-or hOCT3-transfected MDCK cells and that in mock cells. Because the uptake of NC in MDCK-hOCT1 and MDCK-hOCT3 cells was much higher than that in mock cells, the IC 50 of NC-induced toxicity in the hOCT1-or hOCT3-transfected MDCK cells was significantly lower than that in mock cells (Fig. 5A) . On the other hand, although we did not compare the protein expression of MATE1 and OCT1 in the two cell models, mRNA expression was determined by reverse-transcription polymerase chain reaction. MDCK-hOCT1 and MDCK-hMATE1 cells had ;14,400-and ;14,000-fold increases in mRNA of OCT1 and MATE1 compared with mock cells. Moreover, the activity of hOCT1 and hMATE1 was confirmed by comparing the uptake of model substrate, MPP + (1 mM; 3 minutes), in MDCK-hOCT1, MDCK-hMATE1, and mock cells. The uptake of MPP + in MDCK-hMATE1 and MDCK-hOCT1 cells was 62-and 48-fold of that in mock cells, indicating that hMATE1 had a similar transport capacity for MPP + compared with hOCT1. Schaefer et al. (2012) found that absolute protein expression levels of OCT1 were higher than those of MATE1 in the sandwich cultured human hepatocytes. Additionally, the values of CL int (V max /K m ), correlation with the maximum uptake rate, and affinity for the transporter mean in vitro transport capacity (Deng et al., 2008) . Therefore, based on the data that the uptake of NC (1 mM; 2 minutes) in MDCKhOCT1 and MDCK-hMATE1 cells was 22.5-and 5.5-fold of that in mock cells and the values of CL int were 20.6 and 312 ml/mg protein per minute, respectively, we inferred that the transport capacity of OCT1 was much higher than that of MATE1. Because the passive permeation of NC 1232 Li et al. was extremely low and the transport capacity of OCT1 might be much higher than that of MATE1, we deduced that even if NC was a substrate of the efflux transporters, such as P-glycoprotein (P-gp), the role of OCT1 and OCT3 in hepatocyte accumulation was also important. Thus, the above results suggested that OCT1 and/or OCT3 might play a crucial role in the toxicity of NC. In addition, considering the localization of OCTs and the purpose of the present study, we did not show the interaction of NC with OCT2, an uptake transporter specifically located in renal tubular cells (Burger et al., 2010; Yonezawa and Inui, 2011) , in the current study.
Previous studies had reported similar activities of OCTs in hepatocytes from rats and humans (Jigorel et al., 2005) , and rat liver CYP3A exhibits 73% homology of the amino acid sequence, some substrate preference, and functional analogies to human CYP3A4 (Wojcikowski et al., 2012) . Considering the source limitation of human hepatocytes, we applied primary cultured rat hepatocytes to study NC-induced toxicity.
P450 enzymes, the dominant metabolic enzymes in hepatocytes, mediate the metabolism of NC and subsequently affect NC-induced toxicity. Our study revealed that the metabolism of NC in human liver microsomes was significantly inhibited by the inhibitors of P450, such as ketoconazole (inhibitor of CYP3A4), quercetin (CYP2C8), sertraline (CYP2B6), and quinidine (CYP2D6), suggesting that the above isoforms of P450 mediated the metabolism of NC. Although quercetin is a well known inhibitor of CYP2C8, it is also an inhibitor of CYP3A4 (Sergent et al., 2009; Choi et al., 2011) ; therefore, it decreased the metabolism of NC by inhibition of CYP2C8 as well as CYP3A4. In addition, NC was markedly metabolized by rhCYP3A4, with a greater CL int (5.3 ml/h per picomole P450) compared with that of rhCYP2C8 (3.6 ml/h per picomole P450). Considering the high expression of CYP3A4 in human liver (;30% of total P450 content) (Shimada et al., 1994) and that CYP2C8 accounts for only 7% of total P450 content (Shimada et al., 1994; Rendic and Di Carlo, 1997) , we chose CYP3A4 to further study its role in NC-induced hepatocellular toxicity. The results indicated that NC-induced toxicity in MDCKhOCT1 cells was much greater than that in MDCK-hOCT1/hCYP3A4 cells, suggesting that CYP3A4 reduced the NC-induced toxicity in MDCK-hOCT1/hCYP3A4 cells. Thus we inferred that CYP3A4 attenuated the hepatocellular toxicity caused by NC. Although the present study merely confirmed the role of CYP3A4, it could not exclude the similar effects of CYP2D6, CYP2C8, and CYP2B6.
Quinidine, an inhibitor of OCT1 and OCT3, significantly attenuated the NC-induced toxicity in MDCK-hOCT1 and MDCK-hOCT3 cells via inhibition of the NC uptake mediated by hOCT1 and hOCT3. However, it scarcely affected the toxicity of NC in primary cultured rat hepatocytes, in which quinidine reduced the cellular uptake of NC by inhibition of OCT1 and OCT3, and also decreased its metabolism by inhibition of P450 enzymes, especially CYP2D6 and CYP3A4, as quinidine is an inhibitor of CYP2D6 and CYP3A4 (Li, 2009) . Additionally, quinidine is also a potent inhibitor of efflux proteins, such as P-gp (Sziraki et al., 2011) and MATE1 (Gakunju et al., 1995) , which are expressed in the bile canalicular membrane in hepatocytes. Because NC was a substrate of MATE1, quinidine could reduce the efflux of NC from hepatocytes by inhibiting MATE1. On the other hand, the interaction of NC with P-gp was also studied using MDCK-MDR1 cells [MDCK cells transfected with the human MDR1 (multidrug resistance protein 1) gene], and the transport of NC showed no difference between MDCK-MDR1 and MDCK cells(data not shown). Considering the low passive permeability of NC, MDCK-MDR1 cells may not be suitable for assessing the interaction of NC with MDR1. A similar phenomenon was observed by Iwai et al., (2011) , who found that OCT1/MDR1 double-transfected LLC-PK1 cells were more suitable than MDCK-MDR1 cells for studying the interaction between MDR1 and the OCT1 substrates with low passive permeability. Therefore, the OCT1/MDR1 double-transfected MDCK cells would be required to elucidate the interaction of NC with MDR1. On the other hand, (+)-THP obviously decreased the toxicity of NC in primary cultured rat hepatocytes, since (+)-THP is a strong inhibitor of OCT1 and OCT3 and a weak inhibitor of CYP2D6, CYP2C8, and CYP 3A4 (IC 50 . 100 mM) Tu et al., 2013) . Moreover, the cell viability in primary cultured rat hepatocytes treated with 10 and 50 mM (+)-THP was significantly increased (up to 154.5% and 144.5%) compared with the vehicle group (Fig. 6) . Besides the inhibitory effect on OCT1/OCT3 in rat primary hepatocytes and subsequent attenuation of NC-induced toxicity, (+)-THP itself might also have a protective effect against NCinduced toxicity. Considering the high-level expression of hOCT2 and hOCT3 and low expression of P450 enzymes in human kidney and lung (Gorboulev et al., 1997; Nishimura and Naito, 2005; Koepsell et al., 2007) , we speculate that NC-induced toxicity will be more severe in these tissues than in liver. In addition, previous studies reported that hOCT1 was downregulated in human hepatocellular carcinoma (Heise et al., 2012; Lautem et al., 2013) , suggesting that normal hepatocytes may be more sensitive to the toxicity of NC. For this reason, NC might not be a perfect drug candidate for development. Since cell lines such as HepG2, Huh7, L-02, and Chang's cells (Ji et al., 2002; Gomez-Lechon et al., 2010) have low or no expression of transporters and P450 enzymes (Donato et al., 2008; Liguori et al., 2008; Ahlin et al., 2009) , the drug-induced toxicity related to transporters and P450 enzymes could not be evaluated correctly in these cell models; thus, cell models transfected with transporters and P450 enzymes, such as MDCK-hOCT1/hCYP3A4 cells, might be more suitable.
NC occurs in several traditional remedies and plants from different regions of the world (Jullian et al., 2006) ; generally, it is applied as an analgesic by oral ingestion. According to our present results, OCT1 and OCT3 mediate its hepatocellular uptake and P450 enzymes such as CYP3A4 and CYP2C8 mediate its metabolism. Thus, the oral absolute bioavailability of NC is probably very low, which might be the reason that the severe hepatic toxicity has not been reported, although drugs containing NC, such as Liangmianzhen tablets and extracts of Toddalia asiatica (Gakunju et al., 1995) , have been applied widely for many years. The low bioavailability of NC also might be the reason why NC was administered via i.v. injection for anticancer experiments in animal models.
In conclusion, the present study demonstrated that NC is a highaffinity substrate of hOCT1 and hOCT3, which mediate the hepatocellular uptake of NC and subsequently induce hepatotoxicity. Meanwhile, P450 enzymes, such as CYP3A4, mediate the metabolism of NC and attenuate its hepatic toxicity. Our results for the first time highlight the vital roles of OCT1, OCT3, and CYP3A4 in the hepatic toxicity of NC. The results provide useful information for the future development of NC.
